Accelerate to discover

Back to filter

Related topics

Download today your IsoPlexis e-book: understanding immune Cell Function In Cancer

IsoPlexis

Dec 1, 2021

Understanding complex immune-cancer interactions is critical to identifying therapeutic targets, devising novel avenues...

IsoPlexis technology: accelerating decisions in immunotherapy with predictive single-cell response

IsoPlexis

Nov 25, 2021

The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...

Extensive assessment of Cytokine production on the NovoCyte Penteon flow cytometer

Agilent technologies

Nov 23, 2021

Cytokines are small molecules essential for immune cell response to activation by pathogens, autoimmunity, or...

Jan 18, 2022

Discover the advanced Detector Technology in Agilent NovoCyte flow cytometers

Agilent technologies

Nov 8, 2021

This technical overview describes advancements in detector technology, and highlights examples where optimal signal...

Introducing isoLight system - Automated Cellular Proteomics hub

IsoPlexis

Nov 4, 2021

The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...

Jan 18, 2022

Introducing Cytek NEW 25-Color Immunoprofiling Assay & Kit!

Cytek Biosciences

Oct 25, 2021

To unleash the power of the Cytek full spectrum cytometry system, Cytek scientists designed and developed the 25-Color...

Show all topics (10)

Intelligent immune target screening

Feb 23, 2016

As drug discovery teams turn back to phenotypic screening in the hopes of improving lead identification, high-content imaging (HCI) is becoming the method of choice for secondary compound screens and even primary screens with smaller, directed libraries. But these systems are optimized for adherent cells, leaving researchers who are focused on suspension cells, such as immune cells, with either low-throughput methods like flow cytometry and microscopy, or low-content methods like plate readers. In addition, high-end HCI systems can be expensive, finicky, and complicated to use, with long per-plate data acquisition times.

The iQue Screener is filling this gap by enabling high-throughput high-content screening of suspension cells. Easily screen large libraries formatted in 96-, 384- or 1536-well plates, generating rich, multi-readout datasets in a fraction of the time that a high-end high-content imaging system takes. Get the data you need to prioritize compounds and move your discovery program into high gear with the iQue Screener.

Application
Product news

Related technologies: Conventional flow cytometry | HTP Screening

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey